OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity
Samar Hamdy, Ommoleila Molavi, Zengshuan Ma, et al.
Vaccine (2008) Vol. 26, Iss. 39, pp. 5046-5057
Closed Access | Times Cited: 248
Samar Hamdy, Ommoleila Molavi, Zengshuan Ma, et al.
Vaccine (2008) Vol. 26, Iss. 39, pp. 5046-5057
Closed Access | Times Cited: 248
Showing 1-25 of 248 citing articles:
PLGA-based nanoparticles: An overview of biomedical applications
Fabienne Danhier, Eduardo Ansorena, Joana M. Silva, et al.
Journal of Controlled Release (2012) Vol. 161, Iss. 2, pp. 505-522
Closed Access | Times Cited: 3206
Fabienne Danhier, Eduardo Ansorena, Joana M. Silva, et al.
Journal of Controlled Release (2012) Vol. 161, Iss. 2, pp. 505-522
Closed Access | Times Cited: 3206
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Ronnie H. Fang, Che‐Ming Jack Hu, Brian T. Luk, et al.
Nano Letters (2014) Vol. 14, Iss. 4, pp. 2181-2188
Open Access | Times Cited: 1289
Ronnie H. Fang, Che‐Ming Jack Hu, Brian T. Luk, et al.
Nano Letters (2014) Vol. 14, Iss. 4, pp. 2181-2188
Open Access | Times Cited: 1289
Applications of nanotechnology for immunology
Douglas M. Smith, Jakub K. Simon, James R. Baker
Nature reviews. Immunology (2013) Vol. 13, Iss. 8, pp. 592-605
Open Access | Times Cited: 698
Douglas M. Smith, Jakub K. Simon, James R. Baker
Nature reviews. Immunology (2013) Vol. 13, Iss. 8, pp. 592-605
Open Access | Times Cited: 698
Synthetic Nanoparticles for Vaccines and Immunotherapy
Darrell J. Irvine, Melissa C. Hanson, Kavya Rakhra, et al.
Chemical Reviews (2015) Vol. 115, Iss. 19, pp. 11109-11146
Open Access | Times Cited: 696
Darrell J. Irvine, Melissa C. Hanson, Kavya Rakhra, et al.
Chemical Reviews (2015) Vol. 115, Iss. 19, pp. 11109-11146
Open Access | Times Cited: 696
Materials engineering for immunomodulation
Jeffrey A. Hubbell, Susan N. Thomas, Melody A. Swartz
Nature (2009) Vol. 462, Iss. 7272, pp. 449-460
Open Access | Times Cited: 531
Jeffrey A. Hubbell, Susan N. Thomas, Melody A. Swartz
Nature (2009) Vol. 462, Iss. 7272, pp. 449-460
Open Access | Times Cited: 531
Biomaterials and emerging anticancer therapeutics: engineering the microenvironment
Luo Gu, David Mooney
Nature reviews. Cancer (2015) Vol. 16, Iss. 1, pp. 56-66
Open Access | Times Cited: 386
Luo Gu, David Mooney
Nature reviews. Cancer (2015) Vol. 16, Iss. 1, pp. 56-66
Open Access | Times Cited: 386
Cytokines as biomarkers of nanoparticle immunotoxicity
Mahmoud Elsabahy, Karen L. Wooley
Chemical Society Reviews (2013) Vol. 42, Iss. 12, pp. 5552-5552
Open Access | Times Cited: 376
Mahmoud Elsabahy, Karen L. Wooley
Chemical Society Reviews (2013) Vol. 42, Iss. 12, pp. 5552-5552
Open Access | Times Cited: 376
Exosome-based tumor antigens–adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA
Masaki Morishita, Yuki Takahashi, A. Matsumoto, et al.
Biomaterials (2016) Vol. 111, pp. 55-65
Closed Access | Times Cited: 319
Masaki Morishita, Yuki Takahashi, A. Matsumoto, et al.
Biomaterials (2016) Vol. 111, pp. 55-65
Closed Access | Times Cited: 319
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations
Samar Hamdy, Azita Haddadi, Ryan Hung, et al.
Advanced Drug Delivery Reviews (2011) Vol. 63, Iss. 10-11, pp. 943-955
Closed Access | Times Cited: 281
Samar Hamdy, Azita Haddadi, Ryan Hung, et al.
Advanced Drug Delivery Reviews (2011) Vol. 63, Iss. 10-11, pp. 943-955
Closed Access | Times Cited: 281
Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment
Zhenghong Xu, Yuhua Wang, Lu Zhang, et al.
ACS Nano (2014) Vol. 8, Iss. 4, pp. 3636-3645
Open Access | Times Cited: 265
Zhenghong Xu, Yuhua Wang, Lu Zhang, et al.
ACS Nano (2014) Vol. 8, Iss. 4, pp. 3636-3645
Open Access | Times Cited: 265
Immune system targeting by biodegradable nanoparticles for cancer vaccines
Joana M. Silva, Mafalda Videira, Rogério Gaspar, et al.
Journal of Controlled Release (2013) Vol. 168, Iss. 2, pp. 179-199
Closed Access | Times Cited: 226
Joana M. Silva, Mafalda Videira, Rogério Gaspar, et al.
Journal of Controlled Release (2013) Vol. 168, Iss. 2, pp. 179-199
Closed Access | Times Cited: 226
PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity
Ana Luísa Silva, Peter C. Soema, Bram Slütter, et al.
Human Vaccines & Immunotherapeutics (2016) Vol. 12, Iss. 4, pp. 1056-1069
Open Access | Times Cited: 217
Ana Luísa Silva, Peter C. Soema, Bram Slütter, et al.
Human Vaccines & Immunotherapeutics (2016) Vol. 12, Iss. 4, pp. 1056-1069
Open Access | Times Cited: 217
Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis
Zhenghong Xu, Srinivas Ramishetti, Yu-Cheng Tseng, et al.
Journal of Controlled Release (2013) Vol. 172, Iss. 1, pp. 259-265
Closed Access | Times Cited: 212
Zhenghong Xu, Srinivas Ramishetti, Yu-Cheng Tseng, et al.
Journal of Controlled Release (2013) Vol. 172, Iss. 1, pp. 259-265
Closed Access | Times Cited: 212
Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents
Jiachun Feng, Xunpei Liu, Linheng Li, et al.
Journal of Controlled Release (2013) Vol. 172, Iss. 3, pp. 1020-1034
Closed Access | Times Cited: 211
Jiachun Feng, Xunpei Liu, Linheng Li, et al.
Journal of Controlled Release (2013) Vol. 172, Iss. 3, pp. 1020-1034
Closed Access | Times Cited: 211
Biomaterials for vaccine-based cancer immunotherapy
Rui Zhang, Margaret M. Billingsley, Michael J. Mitchell
Journal of Controlled Release (2018) Vol. 292, pp. 256-276
Open Access | Times Cited: 173
Rui Zhang, Margaret M. Billingsley, Michael J. Mitchell
Journal of Controlled Release (2018) Vol. 292, pp. 256-276
Open Access | Times Cited: 173
Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy
Hyunjoon Kim, Lin Niu, Peter Larson, et al.
Biomaterials (2018) Vol. 164, pp. 38-53
Closed Access | Times Cited: 164
Hyunjoon Kim, Lin Niu, Peter Larson, et al.
Biomaterials (2018) Vol. 164, pp. 38-53
Closed Access | Times Cited: 164
Development of Peptide-Based Vaccines for Cancer
Noraini Abd-Aziz, Chit Laa Poh
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 93
Noraini Abd-Aziz, Chit Laa Poh
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 93
Advancement of cancer immunotherapy using nanoparticles-based nanomedicine
Vemana Gowd, Anas Ahmad, Mohammad Tarique, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 624-644
Closed Access | Times Cited: 83
Vemana Gowd, Anas Ahmad, Mohammad Tarique, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 624-644
Closed Access | Times Cited: 83
Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery
Zhiping Zhang, Songsak Tongchusak, Yo Mizukami, et al.
Biomaterials (2011) Vol. 32, Iss. 14, pp. 3666-3678
Closed Access | Times Cited: 220
Zhiping Zhang, Songsak Tongchusak, Yo Mizukami, et al.
Biomaterials (2011) Vol. 32, Iss. 14, pp. 3666-3678
Closed Access | Times Cited: 220
Biodegradable Nanoparticles as Vaccine Adjuvants and Delivery Systems: Regulation of Immune Responses by Nanoparticle-Based Vaccine
Takami Akagi, Masanori Baba, Mitsuru Akashi
Advances in polymer science (2011), pp. 31-64
Closed Access | Times Cited: 213
Takami Akagi, Masanori Baba, Mitsuru Akashi
Advances in polymer science (2011), pp. 31-64
Closed Access | Times Cited: 213
Biodegradable Particles as Vaccine Delivery Systems: Size Matters
Vijaya B. Joshi, Sean M. Geary, Aliasger K. Salem
The AAPS Journal (2012) Vol. 15, Iss. 1, pp. 85-94
Open Access | Times Cited: 211
Vijaya B. Joshi, Sean M. Geary, Aliasger K. Salem
The AAPS Journal (2012) Vol. 15, Iss. 1, pp. 85-94
Open Access | Times Cited: 211
Nanoparticle Delivery Systems in Cancer Vaccines
Yogita Krishnamachari, Sean M. Geary, Caitlin D. Lemke, et al.
Pharmaceutical Research (2010) Vol. 28, Iss. 2, pp. 215-236
Open Access | Times Cited: 209
Yogita Krishnamachari, Sean M. Geary, Caitlin D. Lemke, et al.
Pharmaceutical Research (2010) Vol. 28, Iss. 2, pp. 215-236
Open Access | Times Cited: 209
Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics
Jianqiu Wang, Meihua Sui, Weimin Fan
Current Drug Metabolism (2010) Vol. 11, Iss. 2, pp. 129-141
Closed Access | Times Cited: 189
Jianqiu Wang, Meihua Sui, Weimin Fan
Current Drug Metabolism (2010) Vol. 11, Iss. 2, pp. 129-141
Closed Access | Times Cited: 189
Macrophage and dendritic cell phenotypic diversity in the context of biomaterials
Peng Meng Kou, Julia E. Babensee
Journal of Biomedical Materials Research Part A (2010) Vol. 96A, Iss. 1, pp. 239-260
Closed Access | Times Cited: 181
Peng Meng Kou, Julia E. Babensee
Journal of Biomedical Materials Research Part A (2010) Vol. 96A, Iss. 1, pp. 239-260
Closed Access | Times Cited: 181
Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles
Guangsheng Du, Rania M. Hathout, Maha Nasr, et al.
Journal of Controlled Release (2017) Vol. 266, pp. 109-118
Open Access | Times Cited: 143
Guangsheng Du, Rania M. Hathout, Maha Nasr, et al.
Journal of Controlled Release (2017) Vol. 266, pp. 109-118
Open Access | Times Cited: 143
